Randomised Controlled Trial To Compare The effects of G-CSF(Granocyte™) And Autologous Bone Marrow Progenitor Cells On Quality Of Life And Left Ventricular Function In Patients with Idiopathic Dilated Cardiomyopathy - REGENERATE-DCM

Overview

No summary available.

Registry

who.int

Start Date

March 17, 2010

End Date

TBD

Last Updated

10 years ago

Study Type

Interventional clinical trial of medicinal product

Sex

All

Sponsor

•60 symptomatic patients with a confirmed diagnosis of dilated cardiomyopathy (NYHA II\-III) attending a ‘Heart Failure clinic’ who are on optimal heart failure treatment, with no further treatment options, under supervision from their physician or heart failure nurse specialist.
•Patients who are NYHA II that have been hospitalised with a dilated cardiomyopathy related condition.
•Prior to recruitment to the study patients at risk of ventricular arrhythmia will have undergone electrophysiological assessment and appropriate clinical management (including implantable defibrillator insertion) where indicated (as per NICE guidelines).
•Coronary angiography will be performed where necessary to confirm the diagnosis and ensure no other conventional treatment options are indicated.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1\.2 Adults (18\-64 years) yes
•F.1\.2\.1 Number of subjects for this age range
•F.1\.3 Elderly (\>\=65 years) yes
•F.1\.3\.1 Number of subjects for this age range

•Patients who satisfy one or more of the following criteria are not suitable for inclusion in the study:
•Documented ejection fraction \>45% (any imaging modality)
•The presence of cardiogenic shock
•The presence of acute left and/or right sided pump failure as judged by the presence of pulmonary oedema and/or new peripheral oedema
•Known severe pre\-existent left ventricular dysfunction (ejection fraction \<10%) prior to randomisation
•Congenital cardiac disease
•Cardiomyopathy secondary to a reversible cause that has not been treated e.g. thyroid disease, alcohol abuse, hypophosphataemia, hypocalcaemia, cocaine abuse, selenium toxicity \& chronic uncontrolled tachycardia
•Cardiomyopathy in association with a neuromuscular disorder e.g. Duchenne’s progressive muscular dystrophy
•Previous cardiac surgery
•Contra\-indication for bone marrow aspiration